Literature DB >> 3556459

Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence.

G L Kovács, F Laczi, M Vecsernyés, K Hódi, G Telegdy, F A László.   

Abstract

Immunoreactive oxytocin (OXT) and arginine8-vasopressin (AVP) levels were measured in limbic areas of the mouse brain (hippocampus, amygdala and basal forebrain). Peptides were measured by radioimmunoassay (RIA). Acute morphine treatment caused a naloxone-reversible increase in OXT content in all three brain regions. The AVP contents of the same brain areas, on the other hand, were not affected by acute morphine treatment. In mice rendered tolerant to/dependent on morphine with subcutaneous morphine pellets, the OXT levels in the limbic brain structures were in the control range (basal forebrain and amygdala) or even decreased (hippocampus). In the latter brain structure of the tolerant animals, the AVP content was also decreased. Naloxone-precipitated withdrawal syndrome in the tolerant/dependent animals resulted in abrupt increases in the OXT and AVP levels of the hippocampus and in the OXT content of the basal forebrain structures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556459     DOI: 10.1007/BF00236302

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  21 in total

1.  Facilitation of development of resistance to morphine analgesia by desglycinamide9-lysine vasopressin.

Authors:  W A Krivoy; E Zimmermann; S Lande
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

2.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

3.  Des-Gly9-[Arg8]-vasopressin may facilitate methadone detoxification of heroin addicts.

Authors:  G van Beek-Verbeek; H M Fraenkel; J M van Ree
Journal:  Subst Alcohol Actions Misuse       Date:  1983

4.  [3H]oxytocin binding sites in the rat brain demonstrated by quantitative light microscopic autoradiography.

Authors:  R E Brinton; J K Wamsley; K W Gee; Y P Wan; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

5.  Comparison of the distribution of oxytocin and vasopressin in the rat brain.

Authors:  J Hawthorn; V T Ang; J S Jenkins
Journal:  Brain Res       Date:  1984-07-30       Impact factor: 3.252

6.  Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/withdrawal are mediated by the limbic system.

Authors:  G L Kovács; F Izbéki; Z Horváth; G Telegdy
Journal:  Behav Brain Res       Date:  1984-10       Impact factor: 3.332

7.  Vasopressin and oxytocin release in the brain--a synaptic event.

Authors:  R M Buijs; J J Van Heerikhuize
Journal:  Brain Res       Date:  1982-12-02       Impact factor: 3.252

8.  Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior.

Authors:  F Laczi; O Gaffori; E R de Kloet; D de Wied
Journal:  Brain Res       Date:  1983-02-07       Impact factor: 3.252

9.  Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain.

Authors:  G L Kovács; Z Horváth; Z Sarnyai; M Faludi; G Telegdy
Journal:  Neuropharmacology       Date:  1985-05       Impact factor: 5.250

10.  Acute morphine treatment and morphine tolerance/dependence alter immunoreactive oxytocin levels in the mouse hippocampus.

Authors:  G L Kovács; M Vecsernyès; F Laczi; M Faludi; G Telegdy; F A Lászlò
Journal:  Brain Res       Date:  1985-02-25       Impact factor: 3.252

View more
  6 in total

1.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

2.  The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.

Authors:  Cassandra O Subiah; Musa V Mabandla; Alisa Phulukdaree; Anil A Chuturgoon; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2012-03-25       Impact factor: 3.584

Review 3.  Oxytocin and opioid addiction revisited: old drug, new applications.

Authors:  Panos Zanos; Polymnia Georgiou; Carol Weber; Fiona Robinson; Christos Kouimtsidis; Ramin Niforooshan; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2017-04-06       Impact factor: 8.739

4.  The effects of beta-endorphin on arginine-8-vasopressin and oxytocin levels in rat brain areas.

Authors:  M Vecsernyés; F Laczi; G L Kovács; G Szabó; T Janáky; G Telegdy; F A László
Journal:  Experientia       Date:  1989-05-15

Review 5.  Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.

Authors:  Carmen Ferrer-Pérez; Marina D Reguilón; José Miñarro; Marta Rodríguez-Arias
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

6.  Oxytocin Attenuates Expression, but Not Acquisition, of Sucrose Conditioned Place Preference in Rats.

Authors:  Devon Patel; Megana Sundar; Eva Lorenz; Kah-Chung Leong
Journal:  Front Behav Neurosci       Date:  2020-12-15       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.